Mergermarket | Private Homecare Giants Taking Stock Of Going Public
Mar 2021
Originally published by Mergermarket in March 2021.
Managing Director in Lincoln’s Healthcare Group, Barry Freeman, provides insights on home health mergers and acquisitions. Click here to view the full article posted on March 22, 2021 by Forbes.
Summary
-
Managing Director in Lincoln’s Healthcare Group, Barry Freeman's insights on home health mergers and acquisitions was featured in Mergermarket.
- Sign up to receive Lincoln's perspectives
Contributor
Meet Professionals with Complementary Expertise in Healthcare
I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.
Dirk-Oliver Löffler
Managing Director | European Co-head Healthcare
FrankfurtRelated Perspectives
What Price is Right? Trends and Opportunities for Private Equity in Pharma Market Access
The cost of developing new drugs is staggering. Among the top 20 global biopharmas, the average cost of developing a candidate from discovery through clinical trials to market was approximately… Read More
Investment Opportunities in Pharma: A Data-Driven Exploration of CDMO Appeal
The report discusses the current state of the contract development and manufacturing organization (CDMO) market within the pharmaceutical industry, emphasizing the increased interest from private equity (PE) investors. The pharmaceutical… Read More
Scrip Asks…What Does 2024 Hold for Biopharma?
James West, Managing Director in Lincoln’s Healthcare Group, recently discussed his expectations for the biopharma market in 2024 as part of Scrip’s series. Part One – Business Strategy and Leadership… Read More